Predicting the Risk of Venous Thromboembolism Recurrence
Supporting Files
-
Feb 24 2012
File Language:
English
Details
-
Alternative Title:Am J Hematol
-
Personal Author:
-
Description:Venous thromboembolism (VTE) is a chronic disease with a 30% ten-year recurrence rate. The highest incidence of recurrence is in the first 6 months. Active cancer significantly increases the hazard of early recurrence, and the proportions of time on standard heparin with an APTT ≥ 0.2 anti-X(a) U/mL, and on warfarin with an INR ≥ 2.0, significantly reduce the hazard. The acute treatment duration does not affect recurrence risk after treatment is stopped. Independent predictors of late recurrence include increasing patient age and body mass index, leg paresis, active cancer and other persistent VTE risk factors, idiopathic VTE, antiphospholipid antibody syndrome, antithrombin, protein C or protein S deficiency, hyperhomocysteinemia and a persistently increased plasma fibrin D-dimer. A recommendation for secondary prophylaxis should be individualized based on the risk for recurrent VTE (especially fatal pulmonary embolism) and bleeding. The appropriateness of secondary prophylaxis should be continuously reevaluated, and the prophylaxis stopped if the benefit no longer exceeds the risk.
-
Subjects:
-
Source:Am J Hematol. 2011; 87(Suppl 1):S63-S67.
-
Pubmed ID:22367958
-
Pubmed Central ID:PMC3383031
-
Document Type:
-
Funding:DD000235/DD/NCBDD CDC HHS/United States ; HG04735/HG/NHGRI NIH HHS/United States ; HL66216/HL/NHLBI NIH HHS/United States ; HL83141/HL/NHLBI NIH HHS/United States ; R01 HL066216/HL/NHLBI NIH HHS/United States ; R01 HL083141/HL/NHLBI NIH HHS/United States ; U01 HG004735/HG/NHGRI NIH HHS/United States
-
Volume:87
-
Collection(s):
-
Main Document Checksum:urn:sha256:6353fda0fd0dc50b79ca50e60e56b16d2cf20a894d2f9d74ad3cc1fc4659b58a
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access